Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 9/2005

01-11-2005

Estimated Urine pH and Bladder Cancer Risk in a Cohort of Male Smokers (Finland)*

Authors: Margaret E. Wright, Dominique S. Michaud, Pirjo Pietinen, Philip R. Taylor, Jarmo Virtamo, Demetrius Albanes

Published in: Cancer Causes & Control | Issue 9/2005

Login to get access
Metadata
Title
Estimated Urine pH and Bladder Cancer Risk in a Cohort of Male Smokers (Finland)*
Authors
Margaret E. Wright
Dominique S. Michaud
Pirjo Pietinen
Philip R. Taylor
Jarmo Virtamo
Demetrius Albanes
Publication date
01-11-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 9/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0348-9

Other articles of this Issue 9/2005

Cancer Causes & Control 9/2005 Go to the issue

Letter to the Editor

Response letter to: Tang H, Greenwood GL, Cowling DW, Lloyd JC, Roeseler AG, Bal DG. Cigarette Smoking Among Lesbians, Gays, and Bisexuals: How Serious a Problem?

OriginalPaper

A Prospective Study of Body Mass Index, Hypertension, and Smoking and the Risk of Renal Cell Carcinoma (United States)

OriginalPaper

The Association Between Cigarette Smoking and Colorectal Polyp Recurrence (United States)

OriginalPaper

Intake of Selenium in the Prevention of Prostate Cancer: a Systematic Review and Meta-analysis*

OriginalPaper

Cancer Incidence among a Cohort of Smokeless Tobacco Users (United States)

OriginalPaper

Childhood Cancer and Social Contact: the Role of Paternal Occupation (United Kingdom)*
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits